MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The prevalence of delirium and subsequent outcomes in inpatients with Parkinson’s disease

F. Gerakios, G. Bate, L. Wright, D. Davis, B. Stephan, L. Robinson, C. Brayne, L. Barnes, G. Stebbins, JP. Taylor, D. Burn, L. Allan, A. Yarnall, S. Richardson, R. Lawson (Newcastle Upon Tyne, United Kingdom)

Meeting: 2023 International Congress

Abstract Number: 444

Keywords: Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To report delirium prevalence in hospitalised Parkinson’s disease (PD) participants compared to older adults and examine the association with mortality in a prospective study.

Background: Parkinson’s disease (PD) is a risk factor for delirium but reported inpatient prevalence varies widely across the literature and is often underreported. Delirium in general older populations can lead to detrimental outcomes such as increased mortality risk, dementia, and institutionalisation, although to date there are no comprehensive prospective studies in PD.

Method: Participants were from the ‘Defining Delirium and its Impact in Parkinson’s Disease’ (DELIRIUM-PD) and the ‘Delirium and Cognitive Impact in Dementia’ (DECIDE) studies. People with PD (DELIRIUM-PD) or older adults from the Cognitive Function and Ageing Study II – Newcastle cohort (DECIDE) admitted to the Newcastle Upon Tyne Hospital Trust were approached to take part.  Delirium was classified prospectively using the Diagnostic and Statistical Manual of Mental Disorders – 5th Edition criteria which takes account of observations, standardised testing and collateral history from informants and hospital staff.  Date of death was determined by medical note reviews approximately 12 months post hospital discharge.

Results: Participants comprised 121 PD participants and 199 older adult controls. Delirium was identified in 38.7% of the controls compared to 66.9% of PD participants (p<.001). In PD, mortality was significantly higher in participants with delirium compared to those without delirium (46.9% vs. 15%, respectively, p<.001). PD participants with delirium had a significantly lower survival probability at approximately 12 months post hospital discharge compared to those without delirium (53.7% vs. 85%, respectively, p<.001) and controls with delirium (71.1%, p=.025). The hazard of mortality in PD participants, after one year was increased by delirium (HR=3.3 [95% CI 1.3-8.6], p=.014) independent of age, sex, clinical frailty, and dementia.

Conclusion: Delirium is more common in inpatients with PD compared to older adults without PD, with over half experiencing a delirium episode. People with PD who experience a delirium episode have an increased risk of mortality within a year of hospital discharge. Further research is essential to accurately identify delirium and thus intervene to potentially prevent it in the PD population.

To cite this abstract in AMA style:

F. Gerakios, G. Bate, L. Wright, D. Davis, B. Stephan, L. Robinson, C. Brayne, L. Barnes, G. Stebbins, JP. Taylor, D. Burn, L. Allan, A. Yarnall, S. Richardson, R. Lawson. The prevalence of delirium and subsequent outcomes in inpatients with Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/the-prevalence-of-delirium-and-subsequent-outcomes-in-inpatients-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-prevalence-of-delirium-and-subsequent-outcomes-in-inpatients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley